MLTX   $47.95  -2.18% Market Closed After Close 48.0 0.10%

MoonLake Immunotherapeutics
Total Cash 519.80M
totalCashPerShare 8.265
EBITDA -78.35M
Total Debt 3.34M
quickRatio 42.459
currentRatio 43.713
Total Revenue
debtToEquity 0.631
Revenue/Share
ROA -0.093210004
ROE -0.11318
grossProfits
freeCashflow -51.42M
operatingCashflow -64.43M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 2.57B
forwardPE -21.22078
floatShares 25.81M
sharesOutstanding 62.89M
sharesShort 7.97M
sharesShortPriorMonth 7.94M
dateShortInterest
sharesPercentSharesOut 0.13%
heldPercentInsiders 0.15%
heldPercentInstitutions 0.96%
Short Ratio help_outline 26.00%
shortPercentOfFloat 0.31%
impliedSharesOutstanding
bookValue 8.281
Price To Book help_outline 5.92
earningsQuarterlyGrowth
netIncomeToCommon -54.80M
trailingEps -0.87%
forwardEps -2.31%
enterpriseToEbitda -32.81
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.44 3Q 2024
institutionsCount 170
lastUpdated Oct. 22, 2024, 7:13 a.m.